Interleukin-2 followed by fluorouracil and folinic acid in refractory colorectal cancer--results of a clinical phase II study.

Hiddemann, W; Ruelfs, C; Ottensmeier, C; Rückle, H; Musch, E; Koch, O; van de Loo, J

Hiddemann, W; Ruelfs, C; Ottensmeier, C; Rückle, H; Musch, E; Koch, O; van de Loo, J.

Affiliation

Hiddemann W; Department of Internal Medicine, University of Münster, Würzburg, Germany.

Semin Oncol ; 19(2 Suppl 3): 225-7, 1992 Apr.

Article in En | MEDLINE | ID: mdl-1557653

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Colorectal Neoplasms/therapy; Adult; Aged; Colorectal Neoplasms/pathology; Drug Evaluation; Fluorouracil/administration & dosage; Fluorouracil/adverse effects; Humans; Interleukin-2/administration & dosage; Interleukin-2/adverse effects; Leucovorin/administration & dosage; Leucovorin/adverse effects; Middle Aged; Neoplasm Metastasis

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Aged / Humans / Middle aged Language: En Year: 1992 Type: Article

Search on Google

XML

PubMed Links